Table 3.

Comparison of patient groups before and after treatment in terms of general condition, endocrine parameters and glucolipid metabolism.

Terms		group 1 (n = 54)		T or Z	P*	group 2 (n = 54)		T or Z	P*	△group1	△group1	T or Z	P*
		Pre-treatment	Post-treatment			Pre-treatment	Post-treatment
Basic conditions	Age	26				25
	Height (cm)	161				162
	Weight (kg)	64.2	61.7	−5.396	<0.001	63.9	61.2	−4.007	<0.001	−3.15 ± 3.11	−2.133 ± 3.64	1.572	0.119
	BMI (kg/m2)	25.35	24.55	−4.591	<0.001	24.65	23.65	−4.158	<0.001	−1.25	−0.85	−0.732	0.464
	Waist-hip ratio	0.88	0.88	−2.377	0.017	0.88	0.87	−0.867	0.386	−0.01	−0.01	−0.903	0.367
	Visceral fat area	115.23 ± 35.17	109.09 ± 30.97	2.771	0.008	109.44 ± 30.48	105.78 ± 28.72	1.832	0.073	−4.70	−3.15	−1.241	0.215
	Body fat percentage	25.89 ± 5.44	34.75 ± 5.89	0.147	0.147	35.00 ± 5.38	34.63 ± 4.90	0.618	0.540	−0.85	−0.10	−1.530	0.126
Endocrine changes	FSH	5.89	5.97	−1.124	0.261	5.71	6.02	−1.881	0.060	0.32	0.27	−0.461	0.645
	LH	9.78	7.47	−2.722	0.006	12.99	7.55	−3.414	<0.001	−1.98	−4.79	−1.220	0.223
	LH/FSH	1.82	1.16	−4.077	<0.001	2.08	1.18	−4.275	<0.001	−0.65	−0.78	−1.238	0.216
	T	1.50 ± 0.59	1.27 ± 0.53	2.944	0.005	1.58 ± 0.58	1.56	−0.194	0.847	−0.27	−0.13	−2.089	0.037
	DHEA	32.14	23.21	−2.614	0.009	29.73	25.17	−2.174	0.030	487 ± 13.26	−5.79 ± 17.17	−0.279	0.781
	DHT	9.74	6.83	−4.244	<0.001	9.18	7.22	−2.587	0.010	−2.29 ± 3.47	-l.34 ± 3.43	1.432	0.155
	FT	9.92	5.28	−4.490	<0.001	7.93	5.74	−5.106	<0.001	−3.14	−2.79	−0.012	0.990
	El	267.4	193.65	−4.736	<0.001	235.85	174.85	−2.915	0.004	•89.62	−53.45)	−2.363	0.018
	E2	136.25	104.0	−2.860	<0.001	128.05	132.35	−1.402	0.161	−44.11	−22.03	−0.826	0.409
	SHBG	36.02	147.70	•5.739	<0.001	42.77	200	−5.704	<0.001	91.24	128.61	−2.529	0.011
	FAI	4.04	0.82	−5.954	<0.001	3.31	1.01	−5.928	<0.001	−3.44	−2.52	−0.568	0.570
Glucose metabolism	CRP	1.21	1.51	−0.198	0.843	0.83	0.55	−2.700	0.007	0.09	−0.29	−1.865	0.062
	FPG	5.40	5.05	−1.519	0.129	5.11 ± 0.57	5.00 ± 0.65	−2.470	0.014	−0.25	−0.30	−0.188	0.198
	FINS	13.99	14.42	−0.495	0.621	14.31	11.31	−1.890	0.059	−0.54	−1.81	−0.919	0.358
	IUCA	276.62	325.70	−1.985	0.047	265.05	269.84	−0.564	0.573	33.06	−4.02	−1.674	0.094
	HOMA-IR	3.74	3.21	−0.254	0.799	3.20	2.48	−2.174	0.030	−0.34	−0.53	−1.115	0.265
	HbAlc	5.15	5.10	−1.072	0.284	5.1610.28	5.1610.28	−2.540	0.011	−0.05	−0.10	−0.754	0.451
	0.5G1U	8.90	8.95	−0.164	0.870	9.18 ± 1.43	8.70 ± 1.23	2.191	0.033	0.45	−0.40	−1.288	0.198
	IhGlu	9.35	9.35	−0.818	0.413	8.97 ± 2.67	8.90 ± 2.09	0.180	0.858	−0.20	−0.05	−0.688	0.491
	2hGlu	7.20	7.30	−0.108	0.914	6.65	7.60	−1.637	0.102	0.00	0.30	−1.202	0.230
	3hGlu	4.80	4.90	.0.173	0.863	4.66 ± 1.07	4.6811.45	−0.061	0.952	0.10	0.15	−0.212	0.832
	0.5hIns	109.45	116.97	−1.795	0.073	102.63	96.59	−0.555	0.579	15.55 ± 66. 19	−8.94 ± 65.79	−1.929	0.056
	Ihlns	117.19	149.47	−2.553	0.011	114.02	125.60	−0.047	0.962	19.10	−10.08	−1.816	0.069
	2hlns	116.10	128.55	−1.649	0.099	99.14	97.75	−0.504	0.614	16.01 ± 66. 35	−8.94 ± 65.79	−1.658	0.100
	3hlns	44.63	35.49	−0.779	0.436	31.18	26.22	−2.001	0.045	−7.94	−3.75	−0.802	0.423
	HOMA•B	185.57	190.14	−0.883	0.377	143.77	138.16	−0.022	0.983	15.80	4.98	−0.752	0.452